EU Pharmaceutical Strategy - Timely patient access to affordable medicines Public Consultation starting today
Pierre Mermet-Bouvier
eCOAs I Regulatory Affairs I Transparency I PMO I Regulatory Intelligence I Clinical Operations I Global and Transversal Teams I Process Improvement I Operational Excellence I Strategic Planning
The European Commission released today for Public Consultation, its "EU Pharmaceutical Strategy for Europe".
As a first step towards its adoption, the Commission published yesterday a roadmap, inviting interested citizens and stakeholders to share their views on the Strategy.
Scheduled to be adopted before the end of the year, the overall objective of the Pharmaceutical Strategy for Europe is to help ensure Europe's supply of safe and affordable medicines and support the European pharmaceutical industry to remain an innovator and world leader.
Citizens, experts and stakeholders are invited to give their feedback to the roadmap, until 07Jul20.
https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/12421-Pharmaceutical-Strategy-Timely-patient-access-to-affordable-medicines
https://ec.europa.eu/health/human-use/strategy_en